Loading...
Somatostatin agonists for treatment of acromegaly
The discovery of somatotropin-release inhibitory factor (SRIF) in hypothalamic extract in 1970 led to the synthesis of the first somatostatin analog octreotide, discovery of five somatostatin receptor subtypes, and development of additional somatostatin receptor ligands (SRL) as pharmacotherapy for...
Na minha lista:
Main Authors: | , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
2007
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2697610/ https://ncbi.nlm.nih.gov/pubmed/18191325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mce.2007.11.024 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|